Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6571)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Uojima H, Hidaka H, Nakayama T, Sung JH, Ichita C, Tokoro S, Masuda S, Sasaki A, Koizumi K, Egashira H, Kako M. Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study. World J Gastroenterol 2017; 23(45): 8062-8072 [PMID: 29259382 DOI: 10.3748/wjg.v23.i45.8062] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i45/8062.htm |
| Number | Citing Articles |
| 1 |
Xiaoyu Li, Xianglei Wang, Menglu Zhao, He Zhang, Chao Liu. The Chemical and Pharmacological Research Progress on a Kind of Chinese Herbal Medicine, Fructus Malvae. Molecules 2022; 27(17): 5678 doi: 10.3390/molecules27175678
|
| 2 |
Masato Nakai, Kenichi Morikawa, Takashi Sasaki, Risako Kohya, Sonoe Yoshida, Shunichi Hosoda, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, Ren Yamada, Masatsugu Ohara, Takuya Sho, Goki Suda, Koji Ogawa, Naoya Sakamoto. Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis. Journal of Gastroenterology 2023; 58(7): 656 doi: 10.1007/s00535-023-01993-w
|
| 3 |
Takuya Iwamoto, Masaki Maeda, Issei Saeki, Isao Hidaka, Kunihiko Tajima, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida. Analysis of tolvaptan non‐responders and outcomes of tolvaptan treatment of ascites. Journal of Gastroenterology and Hepatology 2019; 34(7): 1231 doi: 10.1111/jgh.14524
|
| 4 |
Joanna Bacharewicz-Szczerbicka, Teresa Reduta, Anna Pawłoś, Iwona Flisiak. Paraphenylenediamine and related chemicals as allergens responsible for allergic contact dermatitis. Archives of Medical Science 2021; 17(3): 714 doi: 10.5114/aoms.2019.86709
|
| 5 |
Isao Sakaida, Shuji Terai, Masayuki Kurosaki, Mitsuru Okada, Takahiro Hirano, Yasuhiko Fukuta. Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study). Journal of Gastroenterology 2020; 55(8): 800 doi: 10.1007/s00535-020-01691-x
|
| 6 |
Lucas H. P. Bernts, Joost P. H. Drenth, Eric T. T. L. Tjwa. Management of portal hypertension and ascites in polycystic liver disease. Liver International 2019; 39(11): 2024 doi: 10.1111/liv.14245
|
| 7 |
Miao Li, Zhuofang Bi, Zicheng Huang. Impact of Vaptans on Clinical Outcomes in Cirrhosis Patients: A Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01365
|
| 8 |
Tatsunori Hanai, Makoto Shiraki, Takao Miwa, Satoshi Watanabe, Kenji Imai, Atsushi Suetsugu, Koji Takai, Hisataka Moriwaki, Masahito Shimizu. Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis. Hepatology Research 2019; 49(1): 82 doi: 10.1111/hepr.13244
|
| 9 |
Yasunari Hiramine, Hirofumi Uto, Seiichi Mawatari, Shuji Kanmura, Yasushi Imamura, Takuya Hiwaki, Akiko Saishoji, Manei Oku, Koichi Tokushige, Shigeho Maenohara, Akio Ido. Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites. Journal of Gastroenterology 2021; 56(1): 54 doi: 10.1007/s00535-020-01727-2
|
| 10 |
Masanori Atsukawa, Akihito Tsubota, Koichi Takaguchi, Hidenori Toyoda, Motoh Iwasa, Tadashi Ikegami, Makoto Chuma, Akito Nozaki, Haruki Uojima, Atsushi Hiraoka, Shinya Fukunishi, Keisuke Yokohama, Toshifumi Tada, Keizo Kato, Hiroshi Abe, Joji Tani, Hironao Okubo, Tsunamasa Watanabe, Nobuhiro Hattori, Akemi Tsutsui, Tomonori Senoh, Yuji Yoshida, Tomomi Okubo, Norio Itokawa, Ai Nakagawa‐Iwashita, Chisa Kondo, Taeang Arai, Kojiro Michitaka, Etsuko Iio, Takashi Kumada, Yasushito Tanaka, Yoshiyuki Takei, Katsuhiko Iwakiri. Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. Journal of Gastroenterology and Hepatology 2020; 35(7): 1229 doi: 10.1111/jgh.14965
|
| 11 |
Xin Li, Shidong Liu, Hao Xu, Wence Zhou. Curative Effect and Safety of Tolvaptan Combined With Traditional Diuretics in Treatment of Patients With Cirrhotic Ascites and Relevant Research on Its Dose. American Journal of Therapeutics 2023; 30(2): 158 doi: 10.1097/MJT.0000000000001327
|
| 12 |
Hiroshi Yatsuhashi, Hiromi Sano, Takahiro Hirano, Yoshiyuki Shibasaki. Real‐world hospital mortality of liver cirrhosis inpatients in Japan: a large‐scale cohort study using a medical claims database. Hepatology Research 2021; 51(6): 682 doi: 10.1111/hepr.13635
|
| 13 |
Lu Chai, Zhe Li, Ting Wang, Ran Wang, Kanokwan Pinyopornpanish, Gang Cheng, Xingshun Qi. Efficacy and safety of tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Gastroenterology & Hepatology 2023; 17(10): 1041 doi: 10.1080/17474124.2023.2267421
|
| 14 |
Hiroya Iida, Hiromitsu Maehira, Haruki Mori, Tsuyoshi Maekawa, Masaji Tani. Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-00825-w
|
| 15 |
Hiroshi Yatsuhashi, Hiromi Sano, Takahiro Hirano, Yoshiyuki Shibasaki, Toru Yada. Prevalence of ascites and its treatment in inpatients with liver cirrhosis: a cohort study using a Japanese medical claims database. Kanzo 2020; 61(6): 314 doi: 10.2957/kanzo.61.314
|
| 16 |
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa. First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ Open Gastroenterology 2023; 10(1): e001120 doi: 10.1136/bmjgast-2023-001120
|
| 17 |
Kai Zhang, Yongtai Zhang, Nana Li, Feng Xing, Jihui Zhao, Tao Yang, Chenghai Liu, Nianping Feng. An herbal-compound-based combination therapy that relieves cirrhotic ascites by affecting the L-arginine/nitric oxide pathway: A metabolomics-based systematic study. Journal of Ethnopharmacology 2019; 241: 112034 doi: 10.1016/j.jep.2019.112034
|
| 18 |
Mauro Bernardi, Giacomo Zaccherini. Approach and management of dysnatremias in cirrhosis. Hepatology International 2018; 12(6): 487 doi: 10.1007/s12072-018-9894-6
|